坏死性软组织感染的当前诊断与处理:你需要知道什么
坏死性软组织感染是罕见但高病死率的皮肤软组织细菌感染,表现为快速进展的组织坏死,诊断困难。诊断主要基于细微的体格检查发现、生理不稳定和实验室异常;评分系统和横断面影像可作为辅助,但发现不特异,不应单独据此处理。最常见病原为多微生物感染,也可由梭菌属、A组链球菌、耐甲氧西林金黄色葡萄球菌和水生细菌引起。初始处理包括广谱抗生素、严重脓毒症的液体复苏和早期积极外科清创,常需多次清创以达到感染源控制,一旦控制感染源后可能遗留广泛伤口需多学科伤口管理。近年报告显示病死率较先前报告下降,焦点转向改善发病率。
要点
- 诊断主要依据临床:细微体格检查发现、生理不稳定和实验室异常,评分系统和横断面影像发现不特异,不应单独据此处理。
- 初始处理包括广谱抗生素、严重脓毒症的液体复苏和早期积极外科清创。
- 常需多次手术清创以达到感染源控制,因感染可快速进展,应保持重复清创的低阈值。
- 最常见病原为多微生物感染,特定细菌如梭菌属、A组链球菌、耐甲氧西林金黄色葡萄球菌和水生细菌也可致病。
- 感染源控制后可能遗留广泛伤口,需多学科护理和伤口管理。
适用人群与场景
- 皮肤和软组织坏死性细菌感染患者,包括由多微生物、梭菌属、A组链球菌、耐甲氧西林金黄色葡萄球菌或水生细菌引起者。
处置流程与药物剂量
- 初始处理包括广谱抗生素、严重脓毒症的液体复苏和早期积极外科清创。
- 常需多次手术清创以达到感染源控制,应保持重复清创的低阈值。
- 感染源控制后可能遗留广泛伤口,需多学科护理和伤口管理。
红旗征与不能漏的情况
- 生理不稳定和实验室异常提示坏死性软组织感染可能,需警惕。
研究设计与关键结果
- 坏死性软组织感染罕见,平均外科医生或急诊医疗提供者职业生涯中可能仅见一或两例。
- 近年更多报告显示病死率较先前报告下降,使得关注点转向改善这些感染的发病率。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性
对床旁实践的改变
- 诊断应主要基于临床,评分系统和横断面影像发现不特异,不应单独据此处理。
- 对疑似患者应早期积极外科清创并保持重复清创的低阈值,因感染可快速进展。
- 初始处理包括广谱抗生素和严重脓毒症的液体复苏。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Necrotizing soft tissue infections are rare bacterial infections of the skin and soft tissues with a high morbidity and mortality rate, requiring prompt diagnosis and surgical intervention. These represent a spectrum of disease resulting in tissue necrosis that is rapidly progressive; however, they remain a diagnostic challenge because the average surgeon or emergency medicine provider may only see one or two over the course of their career. Diagnosis is largely clinical and based on subtle physical examination findings, physiologic instability, and laboratory derangements. Aids to diagnosis such as scoring systems and cross-sectional imaging may be used; however, the findings are not specific, so management should not be based on these alone. The most common cause of necrotizing soft tissue infection is polymicrobial infection; however, specific bacteria such as clostridial species, group A streptococcal, methicillin resistant Staphylococcus aureus , and aquatic bacteria may also be causative. Initial management includes broad spectrum antibiotics, fluid resuscitation for severe sepsis, and early aggressive surgical debridement. Often, these patients require multiple operative debridement to achieve source control, and a low threshold for repeat debridement should be maintained because these infections can progress rapidly. Once source control is achieved, patients may be left with extensive wounds requiring multidisciplinary care and wound management. Necrotizing infections have long been viewed based on mortality outcomes alone because of their rarity and severity. Over recent years, more reports have shown a decrease in the mortality rates from those previously reported, allowing for a focus on methods to improve morbidity of these infections.
参考来源
- Bisgaard EK, Bulger EM. Current diagnosis and management of necrotizing soft tissue infections: What you need to know. J Trauma Acute Care Surg. 2024. PMID: 38689406. doi:10.1097/TA.0000000000004351
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。